Cargando…
Pharmacological Unmasking Microarray Approach-Based Discovery of Novel DNA Methylation Markers for Hepatocellular Carcinoma
DNA methylation is one of the main epigenetic mechanisms and hypermethylation of CpG islands at tumor suppressor genes switches off these genes. To find novel DNA methylation markers in hepatocellular carcinoma (HCC), we performed pharmacological unmasking (treatment with 5-aza-2'-deoxycytidine...
Autores principales: | Jung, Namhee, Won, Jae Kyung, Kim, Baek-Hui, Suh, Kyung Suk, Jang, Ja-June, Kang, Gyeong Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369444/ https://www.ncbi.nlm.nih.gov/pubmed/22690089 http://dx.doi.org/10.3346/jkms.2012.27.6.594 |
Ejemplares similares
-
Identification of Novel Methylation Markers in Hepatocellular Carcinoma using a Methylation Array
por: Shin, So Hyun, et al.
Publicado: (2010) -
Prognosis of Hepatocellular Carcinoma after Liver Transplantation: Comparative Analysis with Partial Hepatectomy
por: Lee, Kyuho, et al.
Publicado: (2017) -
A novel prognostic factor for hepatocellular carcinoma: protein disulfide isomerase
por: Yu, Su Jong, et al.
Publicado: (2014) -
DNA methylation markers for breast cancer prognosis: Unmasking the immune component
por: Dedeurwaerder, Sarah, et al.
Publicado: (2012) -
Hepatocellular Carcinoma with Immature T-Cell (T-lymphoblastic) Proliferation
por: Eun, Shin, et al.
Publicado: (2010)